ERBB2 and neoplasm: For example, in a glioblastoma model, bispecific CAR-T cells co-expressing IL13Rα2 and HER2 CAR molecules demonstrated stronger anti-tumor ability and reduced tumor escape than monospecific or HER2 and IL13Rα2 pooled CAR-T cells [26].